BioVie share price logo

BioVie

NASDAQ: BIVI

$1.43

+0.05

(+3.62%)

as on

BioVie Stock Performance

as on October 31, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $1.39
    $1.49
    downward going graph

    2.80%

    Downside

    4.20%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.82
    $3.79
    downward going graph

    42.66%

    Downside

    165.03%

    Upside

    downward going graph

BioVie share price movements today

Previous Close
$1.38
Open
$1.39
Volume
349.7K
Market Cap
$12.7M
Day's Low - High
$1.39 - $1.49
52 Week Low - High
$0.82 - $3.79

BioVie Historical Returns

1 Month Return
-9.21 %
3 Month Return
-3.5 %
1 Year Return
-22.03 %
3 Year Return
-99.64 %
5 Year Return
-99.77 %

BioVie Stock Fundamentals & Key Indicators

Check BioVie market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$12.7M

EPS (TTM)

-3.2

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.46

Industry PE ratio

-2.98

PEG Ratio

-0.00

EBITDA

-22.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-126.02%

BioVie vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BioVie with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Hold$12.7M-99.77%-0.460.00%0.00%
Neutral$85.5B-35.47%-26.84-12.57%0.00%
StrongBuy$134.2B192.00%30.5886.04%0.00%
Buy$83.7B27.94%19.4284.86%0.45%

Stock Returns calculator for BioVie Stock including INR - Dollar returns

The BioVie stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

BioVie investment value today

Current value as on today

₹86,461

Returns

-₹13,539

(-13.54%)

Returns from BioVie Stock

-₹19,209 (-19.21%)

Dollar Impact

₹5,670 (+5.67%)

Analyst Recommendation on BioVie Stock

Based on 6 analysts

HOLD

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'HOLD' rating for BioVie. Average target price of $5.25

BioVie Share Price Target

Get share price movements and forecasts by analysts on BioVie.

What analysts predicted

72.76%UPSIDE

Target Price

$5.25

Current Price

$1.43

Analyzed by

6 Analysts

Target

$5.25

BioVie target price $5.25, a slight upside of 72.76% compared to current price of $1.43. According to 6 analysts rating.

Indian Investors' Interest in BioVie Stock

Search interest for BioVie Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-17% versus previous 30 day period

BioVie Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
0
-
-
-
0
0
0
0
0
Operating Income
-7
-4
-4
-7
-2
-3
-5
-6
-5
-5
EBITDA
-7
-4
-3
-6
-2
-3
-5
-6
-5
-5
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-4
-4
-7
-2
-3
-5
-6
-5
-5
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-8
-4
-4
-7
-2
-3
-5
-6
-5
-5
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

BioVie Annual Profit & Loss

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
0
-
Operating Income
-1
-2
-2
-2
-138
-27
-45
-32
-18
-22
EBITDA
-1
-2
-2
-2
-129
-23
-45
-28
-16
-21
Interest Expense
-
0
0
4
0
2
4
2
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-2
-2
-16
-130
-26
-50
-32
-17
-22
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-1
-2
-2
-16
-130
-26
-50
-32
-17
-22
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

BioVie Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-8
-4
-4
-7
-2
-3
-5
-6
-5
-5
Operating Cash Flow
-5
-4
-3
-8
-1
-5
-3
-4
-7
-4
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
15
-2
0
12
-
-
10
-
-
-
Change in Cash
10
-6
-3
4
-1
-5
7
-4
-7
-4

BioVie Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Net Income
-1
-2
-2
-16
-130
-26
-50
-32
-17
-22,072
Operating Cash Flow
0
0
-2
-1
-10
-18
-40
-27
-19
-19,024
Investing Cash Flow
-
-
-
-
-
-
-14
14
-
-
Financing Cash Flow
0
0
2
1
14
33
55
17
12
10,457
Change in Cash
0
0
0
0
4
14
0
4
-6
-8,567

Global Institutional Holdings in BioVie

Check out the Institutions with significant holdings in BioVie.

Funds
Holdings
TIAA-CREF Funds
0.85%
VANGUARD INDEX FUNDS
0.83%
Vanguard
0.83%
Fidelity Concord Street Trust
0.71%
Northern Funds
0.20%

Insights on BioVie

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, BIVI stock has moved up by 11.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 192.3% return, outperforming this stock by 292.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 720.2% return, outperforming this stock by 741.3%

About BioVie

BioVie Inc. is a clinical-stage biotechnology firm primarily dedicated to the discovery, development, and commercialization of innovative drug treatments across the United States. The company's developmental portfolio includes BIV201, a therapeutic agent that has successfully completed its Phase IIa clinical trial for addressing ascites resulting from chronic liver cirrhosis. Additionally, BioVie is advancing NE3107, which is currently undergoing a Phase III clinical trial for the management of mild to moderate Alzheimer's disease, and is also in a Phase I clinical trial for the treatment of Parkinson's disease. Further preclinical investigations are underway for NE3107, exploring its potential applications in treating multiple myeloma and prostate cancer. Established in 2013, the company adopted its current name, BioVie Inc., in July 2016, having previously operated as NanoAntibiotics, Inc. Its corporate headquarters are situated in Carson City, Nevada.
OrganisationBioVie
Headquarters680 West Nye Lane, Carson City, NV, 89703, US
IndustryBiotechnology
CEOCuong Viet Do

Key Management of BioVie

Name

Title

Mr. David Morse

Senior VP & Chief Regulatory Officer

Mr. Cuong Viet Do M.B.A.

President, CEO & Director

Ms. Joanne Wendy Kim C.P.A.

CFO, Treasurer & Corporate Secretary

Dr. Joseph M. Palumbo M.D.

Executive VP of R&D and Chief Medical Officer

Mr. Clarence N. Ahlem

Senior Vice President of Operations

Dr. Penelope Markham Ph.D.

Senior Vice President of Liver Disease & Long COVID Programs

Ms. Denise Smith

Senior Vice President of Manufacturing & Development

Dr. Christopher L. Reading Ph.D.

Senior Vice President of Alzheimer's Disease Program

FAQs

What is BioVie share price today?

BioVie share price today is $1.43 as on at the close of the market. BioVie share today touched a day high of $1.49 and a low of $1.39.

What is the 52 week high and 52 week low for BioVie share?

BioVie share touched a 52 week high of $3.79 on and a 52 week low of $0.82 on . BioVie stock price today i.e. is closed at $1.43,which is 62.27% down from its 52 week high and 74.39% up from its 52 week low.

What is BioVie's market capitalisation today?

BioVie market capitalisation is $0.00T as on .

How to invest in BioVie Stock (BIVI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for BioVie on INDmoney app. Click on Buy button.

What is the minimum amount required to buy BioVie Stock (BIVI) from India?

Indian investors can start investing in BioVie (BIVI) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in BioVie stock (as per the Rupee-Dollar exchange rate as on ). Based on BioVie share’s latest price of $1.43 as on October 31, 2026 at 8:46 am IST, you will get 6.9930 shares of BioVie. Learn more about fractional shares .

What are the returns that BioVie has given to Indian investors in the last 5 years?

BioVie stock has given -99.77% share price returns and 27.22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?